Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel contraceptive agents reported in recent Wyeth patent

Oct. 22, 2007

Pfizer to cease sales of Exubera

Oct. 19, 2007

FDA approves expanded labeling for Merck & Co.'s Januvia

Oct. 19, 2007

CHMP issues negative opinion for extended Zavesca indication: Niemann Pick disease

Oct. 19, 2007

Xanodyne receives license to XP-21510 for menorrhagia

Oct. 19, 2007

Vitae and Boehringer Ingelheim to codevelop 11beta-HSD1 inhibitors

Oct. 19, 2007

Recent Bayer Schering Pharma patents report novel agents for male contraception

Oct. 18, 2007

Bristol-Myers Squibb licenses SARM program to Pharmacopeia

Oct. 18, 2007

Preclinical data on two novel PPAR modulators from Pierre Fabre

Oct. 18, 2007

Affymax begins patient dosing in phase III trial of Hematide

Oct. 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...